SCHEMBL9180280

SCHEMBL9180280

c1ccc(C(c2ccccc2)N2CCN(CCOc3cccc4ncccc34)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ HTR1A P08908 7/20 0.59
▸ HTR1D P28221 3/20 0.59
▸ HTR1B P28222 3/20 0.59
▸ TDP1 Q9NUW8 1/20 0.53
▸ P2RX7 Q99572 3/20 0.53
▸ ABCB1 P08183 1/20 0.52
▸ ALOX5 P09917 1/20 0.51
▸ SLC6A4 P31645 2/20 0.49
▸ HTR7 P34969 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ ADRB2 P07550 1/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ HTR2C P28335 1/20 0.49
▸ HTR1F P30939 1/20 0.49
▸ ADRA1B P35368 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ HTR2B P41595 1/20 0.49
▸ HTR5A P47898 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9181173 0.94 P2RX7 (0.57) MEN1KMT2AHTR1AHTR1DHTR1B
SCHEMBL9183697 0.93 P2RX7 (0.59) MEN1KMT2AHTR1AHTR1DHTR1B
SCHEMBL9183346 0.84 ABCB1 (0.74) MEN1KMT2ATDP1ABCB1ALDH1A1
SCHEMBL9186320 0.83 ABCB1 (0.59) MEN1KMT2AHTR1AHTR1DHTR1B
SCHEMBL9189012 0.81 ABCB1 (0.57) MEN1KMT2AHTR1AHTR1DHTR1B
SCHEMBL9184024 0.80 ABCB1 (0.69) MEN1KMT2ATDP1ABCB1ALDH1A1
SCHEMBL9183180 0.80 ABCB1 (0.69) MEN1KMT2ATDP1ABCB1ALDH1A1
SCHEMBL9185474 0.80 ABCB1 (0.56) MEN1KMT2AHTR1AHTR1DHTR1B
SCHEMBL9181526 0.80 P2RX7 (0.61) P2RX7HTR7DRD2DRD3
SCHEMBL9186185 0.79 ABCB1 (0.67) MEN1KMT2ATDP1ABCB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 — — US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 — — EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 — — US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 — — US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 — — EP disclosed
Send feedback